Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 20, 2026BJA OpenOpen Access

Rethinking remimazolam: reconciling regulatory positioning with clinical reality

View Full Paper
Ask AI
Bookmark
Share

Authors

TWTheodora WingertJSJ. Robert Sneyd

Discussion

Loading...

Member takes

Overview

Editorial reveals practice patterns and outcomes of remimazolam use in a large health system, indicating a need for clarity in clinical roles.

Key Points

  • This editorial explores the practical use of remimazolam within a large health system, contrasting regulatory limits with real-world applications.
  • Analysis of 9431 cases of remimazolam use in a large United States health system.
  • Observation of recovery times, discharge readiness, and adverse event rates post-administration.
  • Examination of co-administration patterns with other anaesthetics.
  • Rapid recovery observed with remimazolam; critical event rate of 0.7%.
  • Patients showed faster readiness for discharge from the post-anaesthesia care unit and quicker return to baseline on the Richmond Agitation–Sedation Scale after flumazenil administration.
  • Remimazolam is frequently used for anaesthesia induction despite being licensed only for procedural sedation.

Cite This Study

Wingert et al. (2026) studied this question.

synapsesocial.com/papers/6a362e62db0793dc1a536197https://doi.org/10.1016/j.bjao.2026.100567
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Remimazolam in pediatric anesthesia: a systematic review for clinical decision-making2025
  2. 2Current Research Focus and Trends of Remimazolam: A Bibliometric Analysis of the 100 Most Cited Articles2025
  3. 3Remimazolam Enables Faster Sedation Induction and Recovery Compared With Midazolam in Diagnostic Upper Gastrointestinal Endoscopy: A Multicenter Randomized Controlled Trial2025
  4. 4Remimazolam besylate in intravenous conscious sedation for dental treatment: a prospective cohort study2025
  5. 5The efficacy and safety of remimazolam for the management of emergence agitation: a randomized, double-blind, placebo-controlled study2025